NCT02700204View on ClinicalTrials.gov

Histological Study to Evaluate Skin Changes After PicoWay® 1064 nm and 532nm Picosecond Fractional Laser Treatment

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Dyschromia
Interventions
DEVICE

PicoWay 532nm fractional treatment

is a solid state laser capable of delivering energy at dual wavelength of 1064 nm or 532 nm at extremely short durations in the range of 300-900 ps

DEVICE

PicoWay 1064nm fractional treatment

is a solid state laser capable of delivering energy at dual wavelength of 1064 nm or 532 nm at extremely short durations in the range of 300-900 ps

Trial Locations (1)

10028

Arielle N. Kauvar,, New York

All Listed Sponsors
lead

Syneron Medical

INDUSTRY

NCT02700204 - Histological Study to Evaluate Skin Changes After PicoWay® 1064 nm and 532nm Picosecond Fractional Laser Treatment | Biotech Hunter | Biotech Hunter